Navigation Links
Champions Oncology Reports Financial Results for the Quarter Ended July 31, 2012
Date:9/12/2012

d analyzed to determine which drug or drug combination is providing the highest level of tumor growth inhibition.  Our data demonstrates that there is a high correlation between the response to drugs of the tumor in mice with the response of the tumor in the patient.

This press release may contain "forward-looking statements" (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties.  Champions Oncology generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2012 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law.

Champions Oncology, Inc.
 (Dollars in thousands except per share amounts)

 Reconciliation of GAAP to Non-GAAP Net LossQuarter Ended July 3120122011Net loss – GAAP

($1,323)

($2,037)Less: Stock-based compensation

739

1,014Net loss - non-GAAP

($584)

($1,023) Reconciliation of GAAP to Non-GAAP Earnings Per Share (EPS
'/>"/>

SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Champions Oncology to Present at Rodman & Renshaw Conference
2. Champions Oncology Reports Resignation Of Director
3. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
4. Dr. Sophia Rahman to join Diablo Valley Oncologys Radiation Program
5. ONCOLOGY and the Cancer Network Launch "Consultations in Ethics" Feature
6. Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
7. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
8. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
9. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
10. Radiation Therapy in Oncology Drug Pipeline Update 2012
11. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  CVS Caremark Corporation (NYSE: CVS ... August 5, 2014, at 8:30 a.m. (EDT) with analysts ... results. An audio webcast of the conference ... portion of the CVS Caremark website for all interested ... This webcast will be archived and available on the ...
(Date:7/25/2014)...  Acsis Inc., the market leader for supply ... recently posted an article, "Future of Running ... needs for companies, extended supply chain, and explains ... no longer work today.  The article explains how ... mobile technology, machine to machine (M2M) connectivity, and ...
(Date:7/25/2014)... 2014 Research and Markets has ... Devices Market 2014-2018" report to their offering. ... Ophthalmic Diagnostic Device An ophthalmic diagnostic ... defect or deficiency in the human visual pathway. Ophthalmic ... as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... 16 Medicare has been touting the merits of the "competitive" bidding program for durable, or home medical equipment ... facts that exaggerate the benefits and ignore the severe shortcomings of the program. , ... ... , ...
... Pharmaceuticals Inc. (Nasdaq: OSIP ) that it will nominate a full and competing slate of independent directors at OSI Pharmaceuticals, 2010 annual stockholders, meeting. , ... , ... ... ...
Cached Medicine Technology:Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 2Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 3Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 4Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 5Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 2Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 3Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 4Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 5Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 6Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 7Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 8Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 9Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting 10
(Date:7/28/2014)... 2014 Maternal and Family Health Services ... which will be presented at the agency’s 43rd Annual ... at the Westmoreland Club in Wilkes-Barre. , The late ... long-time employee of MFHS. She dedicated her life ... health advocate, and champion for women, children and families ...
(Date:7/28/2014)... study has found that following a healthy lifestyle may ... syndrome. Published early online in CANCER , a ... indicate that children with cancer and adults who had ... how their lifestyle may influence their long-term health. ... to be at increased risk for the metabolic syndrome, ...
(Date:7/28/2014)... 28, 2014 As health insurers design ... to private exchanges. “Private Exchange Strategies for Insurers: ... from Atlantic Information Services, will provide answers to the ... for the future. , Barbara Gniewek, Jonathan Har-Even and ... experience in the private exchange sector — will provide ...
(Date:7/28/2014)... 28, 2014 Mitul R. Patel, DDS ... at the MGE Management Experts Benefit Dinner May 30, ... joined the Dentists to raise funds for the Improving ... Girls Clubs and Youth Programs across America. The funds ... with books and audio books to directly tackle illiteracy ...
(Date:7/28/2014)... Cuidado Casero , an organization of Medicare certified agencies ... Texas, New Mexico, New Jersey, Virginia, and Puerto Rico, was ... of PAM’s 2014 Gala. , North Texas PAMS is ... Texas chapter was created by a handful of Peruvian physicians ... care for the indigent in Peru. The chapter is developing ...
Breaking Medicine News(10 mins):Health News:MFHS Seeking Nominations for Rose Allan Tucker Award 2Health News:Lifestyle choices may affect the long-term heart health of childhood cancer survivors 2Health News:Three PwC Consultants to Offer Insurers Successful Strategies for Private Exchanges 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 3Health News:Cuidado Casero Sponsors Peruvian American Medical Society (PAMS) Gala 2
... traditional medicinal system, the Indian Council of Medical Research (ICMR) ... develop drugs //from medicinal plants or multi-herb formulations that have ... valid for next five years was signed by ICMR Director ... K Gupta., ,As per the MoU, the ICMR will ...
... shortfall of the tissue culture variety of anti-rabies vaccine, ... of the restricted nerve tissue variety vaccine till the ... minister Surjyakanta Mishra told reporters here today that the ... few years ago citing side-effects., ,"However, since the ...
... shown by an increased nighttime BP than with a traditional ... researchers at Uppsala University revealed that a high blood pressure ... heart failure. ,Congestive heart failure (CHF) is ... Once diagnosed as having CHF, patients have a 1 in ...
... demand for traditional Indian medicine, a four-year degree course ... University (JU) for the first time in eastern India//. ... second of its kind in the country after Gujarat, ... Sciences (BIPS) in joint venture with West Bengal Health ...
... women has shown that those who indulged in six or ... 3 percent reduction in risk of type 2 diabetes, vis ... scientists were not able to place their finger on the ... they strongly feel that the presence of antioxidants and minerals ...
... MMR vaccine has been shrouded in controversy. Now, Britain's reputed ... to the raging //debates over this vaccine. ,Infact they have ... threat to young lives by forsaking the triple shots of ... and the media to defuse the entire furore over the ...
Cached Medicine News:Health News:Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure 2
All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Intended for one-time use....
Used to provide bladder drainage by percutaneous placement of a balloon catheter. Supplied sterile in peel-open packages. Intended for one-time use....
Used to establish and temporarily maintain suprapubic access during endoscopic procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Used for pulling sutures from a vaginal incision into the suprapubic area during bladder suspension surgery. The double needle design permits simultaneous suture placement. Supplied sterile in peel-o...
Medicine Products: